| __timestamp | BioMarin Pharmaceutical Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 751040000 | 20272000000 |
| Thursday, January 1, 2015 | 889895000 | 19652000000 |
| Friday, January 1, 2016 | 1116854000 | 21903000000 |
| Sunday, January 1, 2017 | 1313646000 | 22385000000 |
| Monday, January 1, 2018 | 1491212000 | 18854000000 |
| Tuesday, January 1, 2019 | 1704048000 | 16887000000 |
| Wednesday, January 1, 2020 | 1860455000 | 16658000000 |
| Friday, January 1, 2021 | 1846275000 | 15878000000 |
| Saturday, January 1, 2022 | 2096039000 | 14925000000 |
| Sunday, January 1, 2023 | 2419226000 | 15846000000 |
| Monday, January 1, 2024 | 16544000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, Teva Pharmaceutical Industries Limited and BioMarin Pharmaceutical Inc. have showcased contrasting revenue trajectories over the past decade. From 2014 to 2023, BioMarin's revenue surged by over 220%, reflecting its robust growth strategy and successful product launches. In contrast, Teva experienced a revenue decline of approximately 22%, highlighting the challenges it faced amidst market competition and strategic shifts.
BioMarin's consistent upward trend, peaking at $2.42 billion in 2023, underscores its resilience and innovation in the biotech sector. Meanwhile, Teva's revenue, which reached its zenith in 2017 at $22.39 billion, saw a gradual decline, settling at $15.85 billion in 2023. This divergence in financial performance offers a compelling narrative of strategic adaptation and market dynamics in the pharmaceutical landscape.
Pfizer Inc. vs BioMarin Pharmaceutical Inc.: Annual Revenue Growth Compared
Revenue Insights: Amgen Inc. and BioMarin Pharmaceutical Inc. Performance Compared
Comparing Revenue Performance: Sanofi or BioMarin Pharmaceutical Inc.?
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs TG Therapeutics, Inc.
Revenue Showdown: Teva Pharmaceutical Industries Limited vs Merus N.V.
Revenue Insights: Teva Pharmaceutical Industries Limited and Galapagos NV Performance Compared
Annual Revenue Comparison: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Comparing Revenue Performance: BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.?
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
BioMarin Pharmaceutical Inc. vs ImmunityBio, Inc.: Annual Revenue Growth Compared
Revenue Insights: BioMarin Pharmaceutical Inc. and Celldex Therapeutics, Inc. Performance Compared